Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent
Anne-Julie Cloux(University Hospital of Lausanne), Aimable Nahimana(University of Lausanne), Oussama ElMokh(University of Bern), Mathieu Heulot(University of Lausanne), Dominique Aubry(University Hospital of Lausanne), Lucia Mazzolai, Axel Bellotti(University Hospital of Lausanne), Christian Widmann(University of Lausanne), Karima Bouzourène(University of Lausanne), Francesco Piacente(University of Genoa), Maxime Pellegrin(University of Lausanne), Alessio Nencioni(Ospedale Policlinico San Martino), Michel A. Duchosal(Scripps Health), Michele Cea(Azienda Ospedaliera S.Maria)
Cited by 22
Related Papers
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
|European Heart Journal|2024|818
Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor
|Diabetes|1993|540
Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice.
|The Journal of Experimental Medicine|1990|153